Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health In Tech (HIT) Gains from Sales and Divestitures (2024 - 2025)

Health In Tech has reported Gains from Sales and Divestitures over the past 2 years, most recently at $1.1 million for Q4 2025.

  • Quarterly results put Gains from Sales and Divestitures at $1.1 million for Q4 2025, up 94.73% from a year ago — trailing twelve months through Dec 2025 was $1.1 million (up 94.73% YoY), and the annual figure for FY2025 was $1.1 million, up 94.73%.
  • Gains from Sales and Divestitures for Q4 2025 was $1.1 million at Health In Tech, up from $582901.0 in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for HIT hit a ceiling of $1.1 million in Q4 2025 and a floor of $20334.0 in Q1 2025.